MedPath

Comparative study on Oak gall oil and Triphala oil in the treatment of oral leukoplakia and erythroplakia

Phase 3
Conditions
Health Condition 1: null- oral leukoplakia and erythroplakia
Registration Number
CTRI/2016/10/007415
Lead Sponsor
Dr Sharmila S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Outpatients who are current tobacco users and are diagnosed with either leukoplakia and erythroplakia

Histologically mild or moderate epithelial dysplasia

Exclusion Criteria

Subjects with malignant tumours of oral cavity

Subjects with any systemic diseases

Subjects who are pregnant or lactating

Subjects who are physically and mentally challenged

Subjects with known hypersensitivity to toluidine blue

Subjects with dental conditions such as orthodontic appliances or prostheses that may interfere with the examination

Subjects who are currently receiving any type of cessation, alcohol or illicit drug treatment at the time of recruitment

Subjects who are under medication for systemic illness

Leukoplakia with p2 grading of histopathological evaluation by vanderwaal et al 2000

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath